1. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor “MK-421.”;Gavras;Lancet.,1981
2. Effects of enalapril, a new converting enzyme inhibitor, in hypertension;Ferguson;Clin Pharmacol Therap.,1982
3. Antihypertensive activity of N-[(S)-1-carboxy-3-phenylproply]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo;Gross;J Pharmacol Exp Therap.,1981
4. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats;Sweet;J Pharmacol.,1981
5. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept;Cohn;Am J Cardiol.,1982